Long-term results of radiofrequency ablation in colorectal lung metastases: Single center experience

Oncology Reports

Volumn 22, Issue 4, 2009, Pages 885-891

  Yamakado, Koichiro ^a   Inoue, Yasuhiro ^a   Takao, Motoshi ^a   Takaki, Haruyuki ^a   Nakatsuka, Atsuhiro ^a   Uraki, Junji ^a   Kashima, Masataka ^a   Kusunoki, Masato ^a   Shimpo, Hideto ^a   Takeda, Kan ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Colorectal cancer; Complication; Long term follow up; Lung metastasis; Prognosis; Radiofrequency ablation

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; COLORECTAL CANCER; FEMALE; HUMAN; INTUBATION; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; PLEURA EFFUSION; PLEURISY; PNEUMOTHORAX; PRIORITY JOURNAL; PROGNOSIS; RADIOFREQUENCY ABLATION; SURVIVAL RATE; SURVIVAL TIME; TREATMENT RESPONSE; TUMOR GROWTH;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CATHETER ABLATION; COLORECTAL NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 70350366169     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000513     Document Type: Article

References (24)

1. Landis SH, Murray T, Bolden S and Wingo PA: Cancer statistics, 1999. CA Cancer J Clin 49: 8-31, 1999.
2. Davidson RS, Nwogu CE, Brentjens MJ and Anderson TM: The surgical management of pulmonary metastasis: current concepts. Surg Oncol 10: 35-42, 2001.
3. Penna C and Nordlinger B: Colorectal metastasis (liver and lung). Surg Clin North Am 82: 1075-1090, 2002.
4. Pfannschmidt J, Muley T, Hoffmann H and Dienemann H: Prognostic factors and survival after complete resection of pulmonary metastases from colorectal carcinoma: experiences in 167 patients. J Thorac Cardiovasc Surg 126: 732-739, 2003.
5. Saito Y, Omiya H, Kohno K, et al: Pulmonary metastasectomy for 165 patients with colorectal carcinoma: a prognostic assessment. J Thorac Cardiovasc Surg 124: 1007-1013, 2002.
6. Shiono S, Ishii G, Nagai K, et al: Histopathologic prognostic factors in resected colorectal lung metastases. Ann Thorac Surg 79: 278-282, 2005.
7. Kelly H and Goldberg RM: Systemic therapy for metastatic colorectal cancer: current options, current evidence. J Clin Oncol 23: 4553-4560, 2005.
8. Sanoff HK, Sargent DJ, Campbell ME, et al: Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741. J Clin Oncol 10: 5721-5727, 2008.
9. Akeboshi M, Yamakado K, Nakatsuka A, et al: Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response. J Vasc Interv Radiol 15: 463-470, 2004.
10. Simon CJ, Dupuy DE, DiPetrillo TA, et al: Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology 243: 268-275, 2007.
11. Steinke K, Glenn D, King J, et al: Percutaneous imaging-guided radiofrequency ablation in patients with colorectal pulmonary metastases: 1-year follow-up. Ann Surg Oncol 11: 207-212, 2004.
12. Yamakado K, Hase S, Matsuoka T, et al: Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: a multicenter study in Japan. J Vasc Interv Radiol 18: 393-398, 2007.
13. Hiraki T, Gobara H, Iishi T, et al: Percutaneous radiofrequency ablation for pulmonary metastases from colorectal cancer: midterm results in 27 patients. J Vasc Interv Radiol 18: 1264-1269, 2007.
14. Yan TD, King J, Sjarif A, Glenn D, Steinke K and Morris DL: Percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: prognostic determinants for survival. Ann Surg Oncol 13: 1529-1537, 2006.
15. Yan TD, King J, Ebrahimi A, et al: Hepatectomy and lung radiofrequency ablation for hepatic and subsequent pulmonary metastases from colorectal carcinoma. J Surg Oncol 96: 367-373, 2007.
16. Lencioni R, Crocetti L, Cioni R, et al: Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 9: 621-628, 2008.
17. Goldberg SN, Grassi CJ, Cardella JF, et al: Society of Interventional Radiology Technology Assessment Committee. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 235: 728-739, 2005.
18. Bojarski JD, Dupuy DE and Mayo-Smith WW: CT imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: results in 32 tumors. AJR Am J Roentgenol 185: 466-471, 2005.
19. Steinke K, Sewell PE, Dupuy D, et al: Pulmonary radiofrequency ablation-an international study survey. Anticancer Res 24: 339-343, 2004.
20. Inoue Y, Miki C, Hiro J, et al: Improved survival using multimodality therapy in patients with lung metastases from colorectal cancer: a preliminary study. Oncol Rep 14: 1571-1576, 2005.
21. Inoue M, Ohta M, Iuchi K, et al: Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma. Ann Thorac Surg 78: 238-244, 2004.
22. Goldstein MJ and Mitchell EP: Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer. Cancer Invest 23: 338-351, 2005.
23. Gutman M and Fidler IJ: Biology of human colon cancer metastasis. World J Surg 19: 226-234, 1995.
24. Pastorino U, Buyse M, Friedel G, et al: Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg 113: 37-49, 1997.